Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
Gross Profit history
Currency unavailable · from the income statement
No Gross Profit data reported for this period type.
Gross Profit vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $62.98M USD | -26.5% | — | 88.7% | |
| FY2025 | $18.62M USD | — | — | 100.0% | |
| LTM Jun 2026 | $6.56M USD | -89.7% | -39.8% | 92.1% | |
| LTM Mar 2026 | $326K USD | +115.4% | — | 144.9% | |
| LTM Mar 2026 | $0 USD | +100.0% | — | — | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +36.7% | -39.8% | 96.1% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.